| 摘要 |
<p>The present invention relates to an antigenic polypeptide sequence of factor VIII, comprised between the Glutamic Acid 1649 and Asparagine 2019, preferably comprised between Arginine 1652 and Arginine 1917 of the polypeptide sequence of factor VIII, or comprised between Alanine 108 and Methionine 355, or comprised between Aspartic Acid 403 and Aspartic Acid 725, or comprised between Lysine 2085 and Lysine 2249.</p> |
